市場調査レポート

商品コード

1420930

イムノアッセイ市場：世界の業界分析、規模、シェア、成長、動向、および予測、2023～2031年

Immunoassay Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

出版日: 2023年12月14日 | 発行: Transparency Market Research

| ページ情報: 英文 336 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 5,795 908,076円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

PDF (Multi-user License)

USD 8,795 1,378,176円

レポートPDFを同一の部署内・課内の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

PDF (Corporate License)

USD 11,795 1,848,276円

レポートPDFを企業内すべての方に使用頂けるライセンスです。ご利用人数の制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.70円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

イムノアッセイ市場- レポートの範囲

世界の免疫分析市場に関するTMRのレポートは、過去と現在の成長動向、および2023年から2031年の予測期間中に市場の指標の貴重な洞察を得る機会を研究しています。当レポートは、2023年を基準年、2031年を予測年とし、2017年から2031年の期間における世界市場の収益を提供します。また、2023年から2031年までの複合年間成長率（CAGR %）も提供します。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、イムノアッセイ市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

市場スナップショット
2023年の市場価値	315億米ドル
2031年の市場価値	487億米ドル
CAGR	5%

このレポートは、世界のイムノアッセイ市場の競合情勢を詳しく調査しています。世界のイムノアッセイ市場で活動する主要企業が特定され、それぞれの企業がさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界の免疫分析市場のプレーヤーの属性です。

市場プレーヤー-競合マトリックス（企業の階層および規模別）
市場シェア分析：企業別（2022年）
企業プロファイル
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Abbott Laboratories
- Siemens Healthineers（Siemens AG）
- DiaSorin SpA
- Sysmex Corporation
- bioMerieux SA
- Ortho Clinical Diagnostics
- Thermo Fisher Scientific, Inc.
- Becton, Dickinson and Company
- Merck kGaA

図表

List of Tables

Table 01: Global Immunoassay Market Size (US$ Mn) Forecast, by Product, 2017-2031
Table 02: Global Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2017-2031
Table 03: Global Immunoassay Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 04: Global Immunoassay Market Size (US$ Mn) Forecast, by Application, 2017-2031
Table 05: Global Immunoassay Market Size (US$ Mn) Forecast, by Region, 2017-2031
Table 06: North America Immunoassay Market Size (US$ Mn) Forecast, by Country, 2017-2031
Table 07: North America Immunoassay Market Size (US$ Mn) Forecast, by Product, 2017-2031
Table 08: North America Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2017-2031
Table 09: North America Immunoassay Market Size (US$ Mn) Forecast, by Application, 2017-2031
Table 10: North America Immunoassay Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 11: Europe Immunoassay Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 12: Europe Immunoassay Market Size (US$ Mn) Forecast, by Product, 2017-2031
Table 13: Europe Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2017-2031
Table 14: Europe Immunoassay Market Size (US$ Mn) Forecast, by Application, 2017-2031
Table 15: Europe Immunoassay Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 16: Asia Pacific Immunoassay Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 17: Asia Pacific Immunoassay Market Size (US$ Mn) Forecast, by Product, 2017-2031
Table 18: Asia Pacific Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2017-2031
Table 19: Asia Pacific Immunoassay Market Size (US$ Mn) Forecast, by Application, 2017-2031
Table 20: Asia Pacific Immunoassay Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 21: Latin America Immunoassay Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 22: Latin America Immunoassay Market Size (US$ Mn) Forecast, by Product, 2017-2031
Table 23: Latin America Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2017-2031
Table 24: Latin America Immunoassay Market Size (US$ Mn) Forecast, by Application, 2017-2031
Table 25: Latin America Immunoassay Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 26: Middle East & Africa Immunoassay Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 27: Middle East & Africa Immunoassay Market Size (US$ Mn) Forecast, by Product, 2017-2031
Table 28: Middle East & Africa Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2017-2031
Table 29: Middle East & Africa Immunoassay Market Size (US$ Mn) Forecast, by Application, 2017-2031
Table 30: Middle East & Africa Immunoassay Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

Figure 01: Global Immunoassay Market Size (US$ Mn), by Region, 2022 and 2031
Figure 02: Global Immunoassay Market Revenue (US$ Mn), by Product, 2022
Figure 03: Global Immunoassay Market Value Share, by Product, 2022
Figure 04: Global Immunoassay Market Revenue (US$ Mn), by Technology, 2022
Figure 05: Global Immunoassay Market Value Share, by Technology, 2022
Figure 06: Global Immunoassay Market Revenue (US$ Mn), by Application, 2022
Figure 07: Global Immunoassay Market Value Share, by Application, 2022
Figure 08: Global Immunoassay Market Revenue (US$ Mn), by End-user, 2022
Figure 09: Global Immunoassay Market Value Share, by End-user, 2022
Figure 10: Global Immunoassay Market Value Share, by Region, 2022
Figure 11: Global Immunoassay Market Value (US$ Mn) Forecast, 2017-2031
Figure 12: Global Immunoassay Market Value Share Analysis, by Product, 2022 and 2031
Figure 13: Global Immunoassay Market Attractiveness Analysis, by Product, 2023-2031
Figure 14: Global Immunoassay Market Value Share Analysis, by Technology, 2022 and 2031
Figure 15: Global Immunoassay Market Attractiveness Analysis, by Technology, 2023-2031
Figure 16: Global Immunoassay Market Value Share Analysis, by Application, 2022 and 2031
Figure 17: Global Immunoassay Market Attractiveness Analysis, by Application, 2023-2031
Figure 18: Global Immunoassay Market Revenue (US$ Mn), by End-user, 2022
Figure 19: Global Immunoassay Market Value Share, by End-user, 2022
Figure 20: Global Immunoassay Market Value Share Analysis, by Region, 2022 and 2031
Figure 21: Global Immunoassay Market Attractiveness Analysis, by Region, 2023-2031
Figure 22: North America Immunoassay Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
Figure 23: North America Immunoassay Market Attractiveness Analysis, by Country, 2023-2031
Figure 24: North America Immunoassay Market Value Share Analysis, by Country, 2022 and 2031
Figure 25: North America Immunoassay Market Value Share Analysis, by Product, 2022 and 2031
Figure 26: North America Immunoassay Market Value Share Analysis, by Technology, 2022 and 2031
Figure 27: North America Immunoassay Market Value Share Analysis, by Application, 2022 and 2031
Figure 28: North America Immunoassay Market Value Share Analysis, by End-user, 2022 and 2031
Figure 29: North America Immunoassay Market Attractiveness Analysis, by Product, 2023-2031
Figure 30: North America Immunoassay Market Attractiveness Analysis, by Technology, 2023-2031
Figure 31: North America Immunoassay Market Attractiveness Analysis, by Application, 2023-2031
Figure 32: North America Immunoassay Market Attractiveness Analysis, by End-user, 2023-2031
Figure 33: Europe Immunoassay Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
Figure 34: Europe Immunoassay Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 35: Europe Immunoassay Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 36: Europe Immunoassay Market Value Share Analysis, by Product, 2022 and 2031
Figure 37: Europe Immunoassay Market Value Share Analysis, by Technology, 2022 and 2031
Figure 38: Europe Immunoassay Market Value Share Analysis, by Application, 2022 and 2031
Figure 39: Europe Immunoassay Market Value Share Analysis, by End-user, 2022 and 2031
Figure 40: Europe Immunoassay Market Attractiveness Analysis, by Product, 2023-2031
Figure 41: Europe Immunoassay Market Attractiveness Analysis, by Technology, 2023-2031
Figure 42: Europe Immunoassay Market Attractiveness Analysis, by Application, 2023-2031
Figure 43: Europe Immunoassay Market Attractiveness Analysis, by End-user, 2023-2031
Figure 44: Asia Pacific Immunoassay Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
Figure 45: Asia Pacific Immunoassay Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 46: Asia Pacific Immunoassay Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 47: Asia Pacific Immunoassay Market Value Share Analysis, by Product, 2022 and 2031
Figure 48: Asia Pacific Immunoassay Market Value Share Analysis, by Technology, 2022 and 2031
Figure 49: Asia Pacific Immunoassay Market Value Share Analysis, by Application, 2022 and 2031
Figure 50: Asia Pacific Immunoassay Market Value Share Analysis, by End-user, 2022 and 2031
Figure 51: Asia Pacific Immunoassay Market Attractiveness Analysis, by Product, 2023-2031
Figure 52: Asia Pacific Immunoassay Market Attractiveness Analysis, by Technology, 2023-2031
Figure 53: Asia Pacific Immunoassay Market Attractiveness Analysis, by Application, 2023-2031
Figure 54: Asia Pacific Immunoassay Market Attractiveness Analysis, by End-user, 2022-2031
Figure 55: Latin America Immunoassay Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
Figure 56: Latin America Immunoassay Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 57: Latin America Immunoassay Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 58: Latin America Immunoassay Market Value Share Analysis, by Product, 2022 and 2031
Figure 59: Latin America Immunoassay Market Value Share Analysis, by Technology, 2022 and 2031
Figure 60: Latin America Immunoassay Market Value Share Analysis, by Application, 2022 and 2031
Figure 61: Latin America Immunoassay Market Value Share Analysis, by End-user, 2022 and 2031
Figure 62: Latin America Immunoassay Market Attractiveness Analysis, by Product, 2023-2031
Figure 63: Latin America Immunoassay Market Attractiveness Analysis, by Technology, 2023-2031
Figure 64: Latin America Immunoassay Market Attractiveness Analysis, by Application, 2023-2031
Figure 65: Latin America Immunoassay Market Attractiveness Analysis, by End-user, 2023-2031
Figure 66: Middle East & Africa Immunoassay Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
Figure 67: Middle East & Africa Immunoassay Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 68: Middle East & Africa Immunoassay Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 69: Middle East & Africa Immunoassay Market Value Share Analysis, by Product, 2022 and 2031
Figure 70: Middle East & Africa Immunoassay Market Value Share Analysis, by Technology, 2022 and 2031
Figure 71: Middle East & Africa Immunoassay Market Value Share Analysis, by Application, 2022 and 2031
Figure 72: Middle East & Africa Immunoassay Market Value Share Analysis, by End-user, 2022 and 2031
Figure 73: Middle East & Africa Immunoassay Market Attractiveness Analysis, by Product, 2023-2031
Figure 74: Middle East & Africa Immunoassay Market Attractiveness Analysis, by Technology, 2023-2031
Figure 75: Middle East & Africa Immunoassay Market Attractiveness Analysis, by Application, 2023-2031
Figure 76: Middle East & Africa Immunoassay Market Attractiveness Analysis, by End-user, 2023-2031

Product Code: TMRGL19703

Immunoassay Market - Scope of Report

TMR's report on the global immunoassay market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global immunoassay market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global immunoassay market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the immunoassay market.

Market Snapshot
Market Value in 2023	US$ 31.5 Bn
Market Value in 2031	US$ 48.7 Bn
CAGR	5%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global immunoassay market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global immunoassay market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global immunoassay market.

The report delves into the competitive landscape of the global immunoassay market. Key players operating in the global immunoassay market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global immunoassay market profiled in this report.

Key Questions Answered in Global immunoassay Market Report:

What is the sales/revenue generated by immunoassay across all regions during the forecast period?
What are the opportunities in the global immunoassay market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

Immunoassay Market - Research Objectives and Research Approach

The comprehensive report on the global immunoassay market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global immunoassay market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global immunoassay market.

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Immunoassay Market

4. Market Overview

4.1. Introduction
- 4.1.1. Product Definition
- 4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. Global Immunoassay Market Analysis and Forecast, 2017-2031

5. Key Insights

5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry

6. Global Immunoassay Market Analysis and Forecast, by Product

6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2017-2031
- 6.3.1. Analyzers
- 6.3.2. Consumables
6.4. Market Attractiveness, by Product

7. Global Immunoassay Market Analysis and Forecast, by Technology

7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technology, 2017-2031
- 7.3.1. Chemiluminescence Immunoassay (CLIA)
- 7.3.2. Enzyme-linked Immunoassay (ELISA)
- 7.3.3. Enzyme-linked Immunofluorescent Assay (ELFA)
- 7.3.4. Radioimmunoassay (RIA)
- 7.3.5. Others
- 7.3.6. 7.4 Market Attractiveness, by Technology

8. Global Immunoassay Market Analysis and Forecast, by Application

8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2017-2031
- 8.3.1. Infectious Disease
- 8.3.2. Endocrinology
- 8.3.3. Oncology
- 8.3.4. Cardiology
- 8.3.5. Orthopedics
- 8.3.6. Others
8.4. Market Attractiveness, by Application

9. Global Immunoassay Market Analysis and Forecast, by End-user

9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2017-2031
- 9.3.1. Hospitals & Diagnostic Laboratories
- 9.3.2. Blood Banks
- 9.3.3. Others
9.4. Market Attractiveness, by End-user

10. Global Immunoassay Market Analysis and Forecast, by Region

10.1. Key Findings
10.2. Market Value Forecast, by Region, 2017-2031
- 10.2.1. North America
- 10.2.2. Europe
- 10.2.3. Asia Pacific
- 10.2.4. Latin America
- 10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region

11. North America Immunoassay Market Analysis and Forecast

11.1. Introduction
- 11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017-2031
- 11.2.1. Analyzers
- 11.2.2. Consumables
11.3. Market Attractiveness, by Product
11.4. Market Value Forecast, by Technology, 2017-2031
- 11.4.1. Chemiluminescence Immunoassay (CLIA)
- 11.4.2. Enzyme-linked Immunoassay (ELISA)
- 11.4.3. Enzyme-linked Immunofluorescent Assay (ELFA)
- 11.4.4. Radioimmunoassay (RIA)
- 11.4.5. Others
11.5. Market Attractiveness, by Technology
11.6. Market Value Forecast, by Application, 2017-2031
- 11.6.1. Infectious Disease
- 11.6.2. Endocrinology
- 11.6.3. Oncology
- 11.6.4. Cardiology
- 11.6.5. Orthopedics
- 11.6.6. Others
11.7. Market Attractiveness, by Application
11.8. Market Value Forecast, by End-user, 2017-2031
- 11.8.1. Hospitals & Diagnostic Laboratories
- 11.8.2. Blood Banks
- 11.8.3. Others
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country/Sub-region, 2017-2031
- 11.10.1. U.S.
- 11.10.2. Canada
11.11. Market Attractiveness Analysis
- 11.11.1. By Product
- 11.11.2. By Technology
- 11.11.3. By Application
- 11.11.4. By End-user
- 11.11.5. By Country

12. Europe Immunoassay Market Analysis and Forecast

12.1. Introduction
- 12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017-2031
- 12.2.1. Analyzers
- 12.2.2. Consumables
12.3. Market Attractiveness, by Product
12.4. Market Value Forecast, by Technology, 2017-2031
- 12.4.1. Chemiluminescence Immunoassay (CLIA)
- 12.4.2. Enzyme-linked Immunoassay (ELISA)
- 12.4.3. Enzyme-linked Immunofluorescent Assay (ELFA)
- 12.4.4. Radioimmunoassay (RIA)
- 12.4.5. Others
12.5. Market Attractiveness, by Technology
12.6. Market Value Forecast, by Application, 2017-2031
- 12.6.1. Infectious Disease
- 12.6.2. Endocrinology
- 12.6.3. Oncology
- 12.6.4. Cardiology
- 12.6.5. Orthopedics
- 12.6.6. Others
12.7. Market Attractiveness, by Application
12.8. Market Value Forecast, by End-user, 2017-2031
- 12.8.1. Hospitals & Diagnostic Laboratories
- 12.8.2. Blood Banks
- 12.8.3. Others
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.10.1. Germany
- 12.10.2. U.K.
- 12.10.3. France
- 12.10.4. Italy
- 12.10.5. Spain
- 12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
- 12.11.1. By Product
- 12.11.2. By Technology
- 12.11.3. By Application
- 12.11.4. By End-user
- 12.11.5. By Country/Sub-region

13. Asia Pacific Immunoassay Market Analysis and Forecast

13.1. Introduction
- 13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017-2031
- 13.2.1. Analyzers
- 13.2.2. Consumables
13.3. Market Attractiveness, by Product
13.4. Market Value Forecast, by Technology, 2017-2031
- 13.4.1. Chemiluminescence Immunoassay (CLIA)
- 13.4.2. Enzyme-linked Immunoassay (ELISA)
- 13.4.3. Enzyme-linked Immunofluorescent Assay (ELFA)
- 13.4.4. Radioimmunoassay (RIA)
- 13.4.5. Others
13.5. Market Attractiveness, by Technology
13.6. Market Value Forecast, by Application, 2017-2031
- 13.6.1. Infectious Disease
- 13.6.2. Endocrinology
- 13.6.3. Oncology
- 13.6.4. Cardiology
- 13.6.5. Orthopedics
- 13.6.6. Others
13.7. Market Attractiveness, by Application
13.8. Market Value Forecast, by End-user, 2017-2031
- 13.8.1. Hospitals & Diagnostic Laboratories
- 13.8.2. Blood Banks
- 13.8.3. Others
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.10.1. China
- 13.10.2. Japan
- 13.10.3. India
- 13.10.4. Australia & New Zealand
- 13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
- 13.11.1. By Product
- 13.11.2. By Technology
- 13.11.3. By Application
- 13.11.4. By End-user
- 13.11.5. By Country/Sub-region

14. Latin America Immunoassay Market Analysis and Forecast

14.1. Introduction
- 14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017-2031
- 14.2.1. Analyzers
- 14.2.2. Consumables
14.3. Market Attractiveness, by Product
14.4. Market Value Forecast, by Technology, 2017-2031
- 14.4.1. Chemiluminescence Immunoassay (CLIA)
- 14.4.2. Enzyme-linked Immunoassay (ELISA)
- 14.4.3. Enzyme-linked Immunofluorescent Assay (ELFA)
- 14.4.4. Radioimmunoassay (RIA)
- 14.4.5. Others
14.5. Market Attractiveness, by Technology
14.6. Market Value Forecast, by Application, 2017-2031
- 14.6.1. Infectious Disease
- 14.6.2. Endocrinology
- 14.6.3. Oncology
- 14.6.4. Cardiology
- 14.6.5. Orthopedics
- 14.6.6. Others
14.7. Market Attractiveness, by Application
14.8. Market Value Forecast, by End-user, 2017-2031
- 14.8.1. Hospitals & Diagnostic Laboratories
- 14.8.2. Blood Banks
- 14.8.3. Others
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.10.1. Brazil
- 14.10.2. Mexico
- 14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
- 14.11.1. By Product
- 14.11.2. By Technology
- 14.11.3. By Application
- 14.11.4. By End-user
- 14.11.5. By Country/Sub-region

15. Middle East & Africa Immunoassay Market Analysis and Forecast

15.1. Introduction
- 15.1.1. Key Findings
15.2. Market Value Forecast, by Product, 2017-2031
- 15.2.1. Analyzers
- 15.2.2. Consumables
15.3. Market Attractiveness, by Product
15.4. Market Value Forecast, by Technology, 2017-2031
- 15.4.1. Chemiluminescence Immunoassay (CLIA)
- 15.4.2. Enzyme-linked Immunoassay (ELISA)
- 15.4.3. Enzyme-linked Immunofluorescent Assay (ELFA)
- 15.4.4. Radioimmunoassay (RIA)
- 15.4.5. Others
15.5. Market Attractiveness, by Technology
15.6. Market Value Forecast, by Application, 2017-2031
- 15.6.1. Infectious Disease
- 15.6.2. Endocrinology
- 15.6.3. Oncology
- 15.6.4. Cardiology
- 15.6.5. Orthopedics
- 15.6.6. Others
15.7. Market Attractiveness, by Application
15.8. Market Value Forecast, by End-user, 2017-2031
- 15.8.1. Hospitals & Diagnostic Laboratories
- 15.8.2. Blood Banks
- 15.8.3. Others
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2017-2031
- 15.10.1. GCC Countries
- 15.10.2. South Africa
- 15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
- 15.11.1. By Product
- 15.11.2. By Technology
- 15.11.3. By Application
- 15.11.4. By End-user
- 15.11.5. By Country/Sub-region

16. Competition Landscape

16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
- 16.3.1. F. Hoffmann-La Roche Ltd.
  - 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.1.2. Product Portfolio
  - 16.3.1.3. Financial Overview
  - 16.3.1.4. SWOT Analysis
  - 16.3.1.5. Strategic Overview
- 16.3.2. Danaher Corporation
  - 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.2.2. Product Portfolio
  - 16.3.2.3. Financial Overview
  - 16.3.2.4. SWOT Analysis
  - 16.3.2.5. Strategic Overview
- 16.3.3. Abbott Laboratories
  - 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.3.2. Product Portfolio
  - 16.3.3.3. Financial Overview
  - 16.3.3.4. SWOT Analysis
  - 16.3.3.5. Strategic Overview
- 16.3.4. Siemens Healthineers (Siemens AG)
  - 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.4.2. Product Portfolio
  - 16.3.4.3. Financial Overview
  - 16.3.4.4. SWOT Analysis
  - 16.3.4.5. Strategic Overview
- 16.3.5. DiaSorin S.p.A.
  - 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.5.2. Product Portfolio
  - 16.3.5.3. Financial Overview
  - 16.3.5.4. SWOT Analysis
  - 16.3.5.5. Strategic Overview
- 16.3.6. Sysmex Corporation
  - 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.6.2. Product Portfolio
  - 16.3.6.3. Financial Overview
  - 16.3.6.4. SWOT Analysis
  - 16.3.6.5. Strategic Overview
- 16.3.7. bioMerieux SA
  - 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.7.2. Product Portfolio
  - 16.3.7.3. Financial Overview
  - 16.3.7.4. SWOT Analysis
  - 16.3.7.5. Strategic Overview
- 16.3.8. Ortho Clinical Diagnostics
  - 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.8.2. Product Portfolio
  - 16.3.8.3. Financial Overview
  - 16.3.8.4. SWOT Analysis
  - 16.3.8.5. Strategic Overview
- 16.3.9. Thermo Fisher Scientific, Inc.
  - 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.9.2. Product Portfolio
  - 16.3.9.3. Financial Overview
  - 16.3.9.4. SWOT Analysis
  - 16.3.9.5. Strategic Overview
- 16.3.10. Becton, Dickinson and Company
  - 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.10.2. Product Portfolio
  - 16.3.10.3. Financial Overview
  - 16.3.10.4. SWOT Analysis
  - 16.3.10.5. Strategic Overview
- 16.3.11. Merck kGaA
  - 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.11.2. Product Portfolio
  - 16.3.11.3. Financial Overview
  - 16.3.11.4. SWOT Analysis
  - 16.3.11.5. Strategic Overview

イムノアッセイ市場：世界の業界分析、規模、シェア、成長、動向、および予測、2023～2031年

Immunoassay Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

イムノアッセイ市場- レポートの範囲

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

第5章 重要な洞察

第6章 世界市場の分析と予測：製品別

第7章 世界市場の分析と予測：テクノロジー別

第8章 世界市場の分析と予測：用途別

第9章 世界市場の分析と予測：エンドユーザー別

第10章 世界市場の分析と予測：地域別

第11章 北米市場の分析と予測

第12章 欧州市場の分析と予測

第13章 アジア太平洋市場の分析と予測

第14章 ラテンアメリカ市場の分析と予測

第15章 中東およびアフリカ市場の分析と予測

第16章 競合情勢

List of Tables

List of Figures

Immunoassay Market - Scope of Report

Key Questions Answered in Global immunoassay Market Report:

Immunoassay Market - Research Objectives and Research Approach

Table of Contents

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary: Global Immunoassay Market

4. Market Overview

5. Key Insights

6. Global Immunoassay Market Analysis and Forecast, by Product

7. Global Immunoassay Market Analysis and Forecast, by Technology

8. Global Immunoassay Market Analysis and Forecast, by Application

9. Global Immunoassay Market Analysis and Forecast, by End-user

10. Global Immunoassay Market Analysis and Forecast, by Region

11. North America Immunoassay Market Analysis and Forecast

12. Europe Immunoassay Market Analysis and Forecast

13. Asia Pacific Immunoassay Market Analysis and Forecast

14. Latin America Immunoassay Market Analysis and Forecast

15. Middle East & Africa Immunoassay Market Analysis and Forecast

16. Competition Landscape

第1章序文

第2章前提条件と調査手法

第3章エグゼクティブサマリー：世界市場

第4章市場概要

第5章重要な洞察

第6章世界市場の分析と予測：製品別

第7章世界市場の分析と予測：テクノロジー別

第8章世界市場の分析と予測：用途別

第9章世界市場の分析と予測：エンドユーザー別

第10章世界市場の分析と予測：地域別

第11章北米市場の分析と予測

第12章欧州市場の分析と予測

第13章アジア太平洋市場の分析と予測

第14章ラテンアメリカ市場の分析と予測

第15章中東およびアフリカ市場の分析と予測

第16章競合情勢